Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Abstract Background/Objective: Effects of atorvastatin (Lipitor) drug monotherapy (1 0 mg
daily) on fasting blood Iipid profiles and cardiovascular disease (CVD) risks were examined …

Nash MS, Mendez AJ. A guideline-driven assessment of need for cardiovascular disease
risk intervention in persons with chronic paraplegia. OBJECTIVE: To examine percentages …

Context: Fenofibrate is used to treat elevated serum triglyceride (TG) concentrations (eg≥
150 mg/dl). The lipoprotein profile of most individuals with spinal cord injury (SCI) would not …

ASHP supports the use of niacin as an effective therapy for the management of
dyslipidemias in adults. Successful and safe therapy requires ongoing supervision and …

Statins are a class of lipid-lowering medications that reduce illness and mortality in those
who are at a high risk of developing cardiovascular disease. They are the most common …

Background and Purpose—In Atherothrombosis Intervention in Metabolic Syndrome with
low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial, addition of …

Study design: A prospective study during a diet modification. Objective: To observe the
evolution of the plasma lipid profile in a group of spinal cord injury (SCI) patients given a …

The present meta-analysis pooled data from 5 double-blind, placebo-controlled studies in
432 patients with dyslipidemia treated with various doses of extended-release niacin. Data …

Niacin (nicotinic acid) has been used for primary and secondary coronary heart disease
prevention for over 40 years. Until recently clinical trials incorporating niacin as part of an …